<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="32491">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02683694</url>
  </required_header>
  <id_info>
    <org_study_id>iOC</org_study_id>
    <nct_id>NCT02683694</nct_id>
  </id_info>
  <brief_title>Characteristics and Limitations of Intraoperative OCT Supported Membrane Peeling in Macular Diseases</brief_title>
  <official_title>Characteristics and Limitations of Intraoperative OCT Supported Membrane Peeling in Macular Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vienna Institute for Research in Ocular Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vienna Institute for Research in Ocular Surgery</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During the last decade optical coherence tomography (OCT) extended the possibilities for in
      vivo macula diagnostic and was increasingly used for pre- and post-operative imaging of
      retinal diseases. Spectral-domain optical coherence tomography (SD-OCT) with its increased
      scanning speed and image-resolution provides more detailed information of microstructures in
      the macula.

      Epiretinal membrane (ERM), pseudomaculaforamen, maculaforamen and vitreomacular traction
      syndrome are disorders involving the posterior pole of the eyeball with consecutive vision
      loss. In patients with loss of vision and metamorphopsia disturbing their lifestyle,
      vitrectomy and membrane peeling is usually performed to remove traction and the ERM.

      Different study groups showed that intraoperative use of SD-OCT is possible and improves the
      Quality of Peeling surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to assess the benefits and limits of intraoperative OCT (i-OCT), for
      example whether I-OCT assisted membrane peeling is possible without use of dyes for enabling
      better localistion of the ERM during surgery and to compare that scheme with different &quot;gold
      standard&quot; dyes for peeling such as membrane blue dual and triamcinolone. Rationale for that
      study is to work out which setting enables best visualisation of ERM and ILM in i-OCT. A
      limitation of that method seems to be visualisation of the inner limiting membrane (ILM), so
      that dying of the ILM will probably be still necessary in all cases where ILM-peeling is
      sheduled.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of patients that could be peeled without use of a dye</measure>
    <time_frame>intraoperative</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">81</enrollment>
  <condition>Macular Diseases</condition>
  <arm_group>
    <arm_group_label>study arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>iOCT is performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iOCT</intervention_name>
    <description>the number of subjects that can be peeled without dye are assessed</description>
    <arm_group_label>study arm</arm_group_label>
    <other_name>intraoperative OCT (iOCT)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Epiretinal Membrane, lamellar hole of the macula, macular hole and vitreomacular
             traction syndrome

        Exclusion Criteria:

          -  Other diseases of the eye, such as AMD, retinopathia pigmentosa
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver Findl, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vienna Institute for Research in Ocular Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oliver Findl, Prof</last_name>
    <phone>00431910210</phone>
    <email>oliver.findl@wgkk.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christoph Leisser, MD</last_name>
    <phone>00431910210</phone>
    <email>christoph.leisser@wgkk.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VIROS</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Findl, Prof</last_name>
      <phone>00431910210</phone>
      <email>oliver.findl@wgkk.at</email>
    </contact>
    <contact_backup>
      <last_name>Christoph Leisser, MD</last_name>
      <phone>00431910210</phone>
      <email>christoph.leisser@wgkk.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 9, 2016</lastchanged_date>
  <firstreceived_date>February 12, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vienna Institute for Research in Ocular Surgery</investigator_affiliation>
    <investigator_full_name>Prim. Prof. Dr. Oliver Findl, MBA</investigator_full_name>
    <investigator_title>Prim. Prof. Dr. Oliver Findl, MBA</investigator_title>
  </responsible_party>
  <keyword>Epiretinal membrane</keyword>
  <keyword>lamellar holes of the macula</keyword>
  <keyword>macular holes</keyword>
  <keyword>vitreomacular traction syndrome</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
